<i>MBL2</i> and fever during neutropenia in children with acute lymphoblastic leukaemia
Esther M. te Poele(University Medical Center Groningen), Eveline S.J.M. de Bont(Hôpital Saint-Michel), Frank J.G. Scherpen, Tiny G. J. Meeuwsen‐de Boer(University Medical Center Groningen), P.J.A. de Pagter(University Medical Center Utrecht), Mateusz Siedliński(Jagiellonian University), Marc Bierings(University Medical Center Utrecht), H. Marike Boezen(University Medical Center Groningen), Gerard H. Koppelman(University Medical Center Groningen), Willem A. Kamps(Pediatric Oncology Group), Dirkje S. Postma(University Medical Center Groningen)
Cited by 4
Related Papers
An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2010|986
A cellular census of human lungs identifies novel cell states in health and in asthma
|Nature Medicine|2019|966
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
|The Lancet|1998|964
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
|The Lancet Oncology|2009|932
Evidence Based Selection of Housekeeping Genes
|PLoS ONE|2007|772